Healthcare · Diagnostics Research · NYSE
| Market cap | $47.16B |
|---|---|
| Trailing P/E | 27.6 |
| FCF yield | 2.4% |
| Revenue growth (YoY) | +6.7% |
| EPS growth (YoY) | +5.5% |
| FCF/share growth (YoY) | -14.3% |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Diagnostics Research |
Agilent Technologies, Inc. trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →
| Member | Chamber | Trade | Amount | Disclosed |
|---|---|---|---|---|
| Julie Johnson | House | Sell | $1,001 - $15,000 | Aug 5, 2026 |
| Thomas H Tuberville | Senate | Sell | $1,001 - $15,000 | Aug 5, 2026 |
| Thomas H Tuberville | Senate | Sell | $1,001 - $15,000 | Aug 5, 2026 |
| Lisa McClain | House | Sell | $1,001 - $15,000 | Aug 13, 2025 |
| Lisa McClain | House | Buy | $1,001 - $15,000 | Aug 13, 2025 |
| Jefferson Shreve | House | Sell | $15,001 - $50,000 | Jun 22, 2025 |
| Rob Bresnahan | House | Buy | $1,001 - $15,000 | May 31, 2025 |
| Julie Johnson | House | Sell | $1,001 - $15,000 | May 14, 2025 |
| Jefferson Shreve | House | Buy | $15,001 - $50,000 | May 8, 2025 |
| Rob Bresnahan | House | Sell | $1,001 - $15,000 | Apr 28, 2025 |
| Julie Johnson | House | Sell | $1,001 - $15,000 | Apr 14, 2025 |
| Jefferson Shreve | House | Sell | $15,001 - $50,000 | Apr 11, 2025 |